Alexandra Balcom is Chief Financial Officer of Nuvalent, Inc.. Currently has a direct ownership of 61,734 shares of NUVL, which is worth approximately $5.09 Million. The most recent transaction as insider was on Jul 31, 2023, when has been sold 25,000 shares (Class A Common Stock) at a price of $1.08 per share, resulting in proceeds of $27,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.7K
0% 3M change
85.39% 12M change
Total Value Held $5.09 Million

Alexandra Balcom Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2023
BUY
Exercise of conversion of derivative security
$27,000 $1.08 p/Share
25,000 Added 50.0%
25,000 Class A Common Stock

Also insider at

GLYC
GLYCOMIMETICS INC Healthcare
AB

Alexandra Balcom

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on NUVL

Follow Nuvalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVL shares.

Notify only if

Insider Trading

Get notified when an Nuvalent, Inc. insider buys or sells NUVL shares.

Notify only if

News

Receive news related to Nuvalent, Inc.

Track Activities on NUVL